Clinical Trial Update: A Study to Evaluate the Long-term Safety and Efficacy of LBEC0101 in Subjects With Active RA Despite Methotrexate (MTX) [Phase 3]

View source ↗

Summary

Phase 3 trial update reporting completion of long-term safety and efficacy assessment for LBEC0101 in adults with active rheumatoid arthritis on methotrexate.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rheumatoid Arthritis

Drugs mentioned

• LBEC0101 (etanercept)

Snippet

Sponsor: LG Life Sciences | Conditions: Rheumatoid Arthritis | Phase 3 | Status: COMPLETED